Eden Bio Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Eden Bio Ltd - overview
Established
2021
Location
London, -, UK
Primary Industry
Biotechnology
About
Founded in 2021 by Christopher Reynolds (CTO), Rachel Shaw (CEO), and Evgenia Markova, and based in England, UK, Eden Bio Ltd operates as a biotechnology research company that helps fermentation companies to genetically optimize microorganism strains and improve the yield of protein products. In November 2022, Eden Bio Ltd raised GBP 1 million in seed funding led by investor SynBioVen, with participation from Dhyana Capital and Saras Capital. The company employs machine learning to help companies improve protein yield used in the production of industrial enzymes, therapeutics, vegan foods, custom proteins, or media components. The firm offers precision fermentation and tailored microorganisms as cell factories to produce optimized ingredients with protein-producing microorganism strains.
The company intends to use the November 2022 funding to accelerate the growth of capacity and ability of the platform to improve the yield of protein products by using artificial intelligence.
Current Investors
Saras Capital, Dhyana Capital, SynBioVen
Primary Industry
Biotechnology
Sub Industries
Biotechnology
Website
www.eden.bio
Verticals
Artificial Intelligence
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.